• A Phase 1, Double-Blind, Randomised, Placebo-Controlled, First-in-Human Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Oral JNJ-64794964, A Toll-like Receptor-7 Agonist, In Healthy Adults

  Reported by Jules Levin EASL The International Liver Congress, Vienna, Austria, April 10-14, 2019 EASL: Antiviral activity of JNJ-4964... Monday April 29, 2019 | NATAP

• Lilly Wins Appeal Ruling On Alimta

  INDIANAPOLIS - Eli Lilly and Company (NYSE: LLY) has announced that the U.S. Court of Appeals for the Federal Circuit has ruled in the... Monday April 29, 2019 | Inside INdiana Business

• Pharma Giant Teva Is Latest To Recall Popular Blood Pressure, Heart Drug Over Cancer Concerns

  Consumers should speak with their doctors to discuss the recall before they stop taking the drug Monday April 29, 2019 | NBC Connecticut

• Iron Drugs Market To Witness Huge Growth By 2025 | Leading Key Players- Allergan, AMAG Pharmaceuticals, Daiichi Sankyo

  “Iron Drugs Market” Stay up-to-date with Iron Drugs Market offered by HTF MI. Check how key trends and emerging drivers are shaping this... Monday April 29, 2019 | Get News

• How We Are Developing Immunotherapies Relevant To Africa

  The exorbitant costs of cancer drugs make it difficult for public and private health care systems to provide the latest treatments to... Monday April 29, 2019 | The Conversation Africa

• Custo Anual Da Osteoporose No Brasil é De R$ 1,2 Bilhão

  A osteoporose afeta 200 milhões de pessoas no mundo, 10 milhões só no Brasil. Segundo dados de um novo estudo, no mundo, o custo anual de... Monday April 29, 2019 | Panorama Farmacêutico

• Anti-Fungal Drug Market Is Currently Valued At $13.8 Billion And Is Expected To Growth At A CAGR Of 3.7%. This Figure Converts To A Valuation Of $17.7 Billion By 2023. Key Players Are Novartis AG, Pfizer, Merck, Bayer AG, Astellas Pharma, GlaxoSmithKline Plc. And Johnson & Johnson

  Apr 29, 2019 (AmericanNewsHour via COMTEX News Network) -- Description The anti-fungal drug market caters to the infections caused due to... Monday April 29, 2019 | IDC Chase

• Mylan Adapts Model To Changing Health Care System

  Tony Mauro PITTSBURGH — Over the course of the past decade, Mylan has succeeded in refining and expanding its business model in pursuit of... Monday April 29, 2019 | Chain Drug Review

• Medical Plastics Connect At CHINAPLAS 2019

  Benefiting from economic growth, population expansion and an intensifying aging phenomenon, coupled with everyone’s increasing concern... Monday April 29, 2019 | 文传商讯

• Bumrungrad Hospital Raises The Bar Of Innovative Cancer Treatment With Comprehensive Genomic Testing In Thailand

  BANGKOK, April 29, 2019 /PRNewswire/ — Bumrungrad International Hospital is at the forefront of personalized cancer care with comprehensive... Monday April 29, 2019 | Libyan Newswire

• Cosmetic Surgery And Procedure Market Is Estimated To Touch USD 43.9 Billion By 2025

  29 Apr 2019 – The global Cosmetic Surgery and Procedure Market is estimated to touch US$ 43.9 Billion by the completion of the prediction... Monday April 29, 2019 | Express Press Release Distribution

• Chengdu On The Road To Becoming Global Supply Hub

  Streamlined customs and strong transport network favor the southwestern China city Chengdu, capital of Sichuan province, is developing... Monday April 29, 2019 | ChinaDaily.com.cn

• Order Of Luthuli For Professor Veriava

  President Cyril Ramaphosa bestows the Order of Luthuli in Silver to Professor Yosuf “Joe” Veriava. Durban - Freedom fighter and medical... Sunday April 28, 2019 | Sunday Tribune - IOL

• Mutated Gene All The Buzz | Weekend Argus

  2 successes raise hope of cure for HIV/Aids Sunday April 28, 2019 | IOL

• ‘For Migraine Sufferers With Obesity, Losing Weight Can Decrease Headaches’

  For migraine sufferers with obesity, losing weight can decrease headaches and improve quality of life, researchers from Italy and the... Sunday April 28, 2019 | Daily Trust

• Course List

  Clinical Coffee Break – Diagnostic Criteria 12:53 Clinical Coffee Break – Screening Tools 13:24 Clinical Coffee Break – Practice Guidelines... Sunday April 28, 2019 | The Doctor's Channel

• Celgene Corporation And Acceleron Pharma Announce Submission Of Luspatercept Marketing Authorization Application To The European Medicines Agency (EMA) For MDS And Beta-Thalassemia

  (AETOS Wire)-- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced that Celgene has submitted a... Saturday April 27, 2019 | Sudan Commerce News - Arabic

• Pulse Opinion: Ngige Needs A Doctor

  Ngige told some barefaced lies on national television. This Buhari minister needs a doctor to run a quick check on him. Friday April 26, 2019 | Pulse.ng

• Chutes & Ladders—Novartis Nabs GSK Exec For Sandoz CEO

  Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good... Friday April 26, 2019 | FierceBiotech

• Wits Academics Bestowed With National Orders

  Professors Yosuf (Joe) Veriava and Thokozani Majozi are amongst the recipients of the 2019 National Orders. Friday April 26, 2019 | University of The Witwatersrand

• DoJ Expands Crackdown On Medicare Kickback Schemes — Astellas And Amgen To Pay Nearly $125M To Resolve Allegations

  Weeks after Jazz Pharma, Lundbeck and Alexion were disciplined by the US Department of Justice for allegedly employing charitable... Friday April 26, 2019 | Endpoints News

• Biotech Stocks Facing FDA Decision In May 2019

  (RTTNews) - A lot happened in the month of April, from the resignation of FDA Commissioner Scott Gottlieb coming into effect, approval of... Friday April 26, 2019 | Markets Insider- Business Insider

• Cyclone Kenneth Sweeps Through Mozambique – Photos

  Cyclone Kenneth slammed into Mozambique’s Northern Coast on Thursday, just five weeks after the country was pummelled by powerful Cyclone... Friday April 26, 2019 | Club of Mozambique

• UPDATE 1-UK Stocks-Factors To Watch On April 26

  (Adds company news items and futures) April 26 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 4 points higher at 7,438 on... Friday April 26, 2019 | Investing.com - South Africa

• Teva Pharmaceuticals USA, Inc. Issues Voluntary Nationwide Recall Of Losartan Potassium 25 Mg And 100 Mg Tablets USP, Sold Exclusively To Golden State Medical Supply

  PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals USA, Inc. has initiated a voluntary consider within the United States, to the... Friday April 26, 2019 | DailyHeralds

• Astellas Pharma, Amgen To Pay $124.75M To Settle Kickback Charges

  Two pharmaceutical companies have agreed to pay a total of nearly $125 million to resolve allegations that they paid kickbacks through... Friday April 26, 2019 | Boston Herald

• Ramadan Et Le Diabète : Quelques Conseils Pratiques

  Alhousseynou Sall - Dans quelques jours débutera le mois de ramadan. Je me permets ici de faire quelques recommandations importantes aux... Friday April 26, 2019 | Cridem

• Tap Medical Tourism Potential

  THE Cancer Diseases Hospital (CDC) in Lusaka is the flagship institution in positioning Zambia for medical tourism. It is among the few... Friday April 26, 2019 | Zambia Daily Mail

• Teva Pharmaceuticals USA, Inc. Issues Voluntary Nationwide Recall Of Losart

  Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan... Thursday April 25, 2019 | Sogotrade - Barchart.com

• Abbott Laboratories Receives AACE Outstanding Corporate Award

  - PRLog -- Abbott Laboratories is the 2019 recipient of the American Association of Clinical Endocrinologists (AACE) Outstanding Corporate... Thursday April 25, 2019 | PRLog

• UroGen Pharma Announces Early Stage Feasibility Agreement With Janssen

  NEW YORK–(BUSINESS WIRE)–UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address... Thursday April 25, 2019 | Specialty Pharma Journal - Precision & Technology

• Two New Health Policy Briefs On The Health Impacts Of Early Childhood Interventions

  Health Affairs released today the next two Health Policy Briefs in its ongoing series on the social determinants of health.  Together with... Thursday April 25, 2019 | Health Affairs Blog

• Amgen, Astellas Pay $125M To Settle Medicare Kickback Allegations

  Amgen Inc. and Astellas Pharma will pay a total of $125 million to resolve allegations from the Department of Justice that the... Thursday April 25, 2019 | Fox Business

• Here Are Chicago’s Top Multifamily Sales Of March

  More than $330 million was spent on the five biggest sales, the highest monthly total of the year so far Thursday April 25, 2019 | The Real Deal

• Kenya:Liquid Telecom Makes Telemedicine A Reality For The Aga Khan Hospital Mombasa To Deliver Healthcare To Remote Communities

  Hospital goes digital by using Liquid Telecom’s high-speed fibre network to connect with outreach clinics that serve more than 3.5m... Thursday April 25, 2019 | Pan African Vision

• Theeagle.com: Obituaries Published Apr. 25, 2019

  Sue Carolyn Bennett Denman, 80, of Iola, passed away Monday, April 22, 2019. Services will be at 11 a.m. Saturday, April 27, at Restever... Thursday April 25, 2019 | The Eagle

• Halal Nutraceuticals & Vaccines Global Market 2019, Industry Analysis, Growth Trends, Opportunity And Forecast To 2025

  Wiseguyreports.Com Adds “Halal Nutraceuticals & Vaccines 2019-2025 Global Market Survey Industry Key Players – Malaysi, Berhad, Abbott,... Thursday April 25, 2019 | ABNewswire.com

• Next Generation Implants (NGI) Market To Witness Huge Growth By 2025 | Abbott Laboratories, Arthrex, Biotronik, BOSTON SCIENTIFIC

  Thursday April 25, 2019 | Press Releases - Digital Journal

• Kenya And Ghana To Rollout Malaria Vaccine – E-Soft News Syndicate

  Image copyright AFP/Getty Image caption Oreo accompanied the film’s director to its red carpet premiere Oreo the raccoon, the real-life... Thursday April 25, 2019 | Esoft

• Glenmark Receives Approval From Russian Ministry Of Healthcare To Market Momate Rhino Metered Nasal Spray As An Over-the-Counter (OTC) Product

  "Glenmark has built strong capabilities in the area of respiratory and is among the leading players in this therapy in several marke Thursday April 25, 2019 | PR Newswire Global Biotech